Investment Case

We offer a compelling investment proposition.

Share


Why invest in Imperial?

By building a more consumer-focused challenger business and following a disciplined capital allocation framework we are continuing to invest behind our strategy, while maintaining a strong, efficient balance sheet and delivering enhanced shareholder returns.


Revitalised tobacco business

Investment in our brand equity and sales force initiatives has enabled us to balance market share delivery with strong pricing. The tobacco value creation model remains resilient, with affordability enabling sustainable pricing to offset volume declines. In our top five combustible markets that generate c.70% of operating profit, we have grown market share after years of declines. This, combined with a more disciplined focus on our broader market portfolio, is driving improved combustible returns.

 

Revitalised tobacco business

Building a sustainable next generation product business

Next generation products (NGP) offer adult smokers a route to smoking cessation and remain relatively nascent in many markets. As a challenger, our role is to offer consumers a choice where they have already expressed an NGP preference and where we can leverage our existing customer relationships. Our partnership approach to product innovation enables us to adapt swiftly to changing consumer preferences and with our consumer focus and disciplined execution we have built an NGP business that offers choice.

Building a sustainable next generation product business

Self-help initiatives delivering operational improvements

We have identified multiple initiatives to deliver operational improvements that will enhance our decision making and drive efficiencies. For example, we are adopting new ways of working with our enabling functions using a global business service model and implementing a new ERP system to replace our 60 legacy systems.


 


Down arrow

Combined, these are generating a strong financial outlook

Free cash flow generated in FY24 £2.4bn

Improving tobacco and NGP net revenue trajectory, with a compound annual growth rate of 1% to 2%.

Enhancing profitability through operational leverage, better geographic mix from continued stabilisation of priority market shares, reduced losses from our investment in NGP and restructuring cost savings driving a mid single-digit compound annual growth rate for Group adjusted operating profit.

The business is highly cash generative with low capital intensity, a working capital focus and disciplined capital expenditure producing adjusted operating cash conversion of typically 90% to 100%.


Down arrow

Enhancing our capital returns

We have a clear capital allocation framework alongside our strategy:

Capital returns to shareholders committed in FY25 £2.8bn

1. Invest in strategy

Since our strategy is largely organic and we work with innovation partners, our capital expenditure needs are relatively light. Any M&A is likely to be small.

2. Maintain leverage

We are committed to an investment grade credit rating and will maintain our leverage at the lower end of the range 2.0-2.5 times adjusted net debt/EBITDA.

3. Progressive dividend growth

We have committed to grow our dividend every year, taking into account the underlying business performance.

4. Return surplus capital to shareholders

We have an ongoing share buyback programme, with £1.25 billion committed in FY25.


Our use of cookies

We use necessary cookies to make our site work. We’d also like to set optional analytics cookies to help us improve it. We won’t set optional cookies unless you enable them. Using this tool will set a cookie on your device to remember your preferences.

For more detailed information about the cookies we use, see our Cookie policy


Analytics cookies

We’d like to set Google Analytics cookies to help us to improve our website by collecting and reporting information on how you use it. The cookies collect information in a way that does not directly identify anyone.

For more detailed information about the cookies we use, see our Cookie policy

: